TIDMBATS

RNS Number : 6725R

British American Tobacco PLC

09 March 2021

BRITISH AMERICAN TOBACCO p.l.c.

Annual Report for the Year Ended 31 December 2020

In compliance with Listing Rule 9.6.1, British American Tobacco p.l.c. (the "Company") reports that its Annual Report 2020 (including the Strategic Report 2020) and Performance Summary 2020 will be shortly submitted to the National Storage Mechanism and will be available for inspection via the following link: https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

The Company's Annual Report 2020 and Performance Summary 2020 have been published to be viewed or downloaded on the British American Tobacco website at www.bat.com/annualreport .

In addition, in accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, the Company announces that today it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended 31 December 2020. The Annual Report on Form 20-F will be available online at the British American Tobacco website at www.bat.com/annualreport and also online at www.sec.gov .

The Annual Report 2020 and other ancillary shareholder documents will be mailed and made available to shareholders on 17 March 2021. Investors have the ability to receive a hard copy of BAT's complete audited financial statements, free of charge, upon request, by contacting the below:

 
 United Kingdom 
 British American Tobacco        Telephone: +44 20 7511 7797 
  Publications                    Email: bat@team365.co.uk 
                                ----------------------------------------- 
 South Africa 
 The Company's Representative    Telephone: +27 21 003 6712 
  Office 
                                ----------------------------------------- 
 United States 
 Citibank Shareholder Services   Telephone: +1 888 985 2055 
                                  (toll-free) 
                                  Email: citibank@shareholders-online.com 
                                ----------------------------------------- 
 

The Company's Sustainability Report 2020 will be available online at the British American Tobacco website at www.bat.com.

The Company made its preliminary announcement of its audited results (which included a condensed set of the Company's financial statements, extracts of the management report and a Directors' responsibility statement) in respect of the year ended 31 December 2020 (the "Preliminary Announcement") on 17 February 2021. Further to the Preliminary Announcement and with reference to the requirements of Rule 6.3.5 of the Disclosure Guidance and Transparency Rules, the following disclosures are made in the Appendices below.

Appendix A to this announcement contains a description of the Group Principal Risks (page 84 of the Annual Report 2020), Appendix B is a statement of related party disclosures (page 222 of the Annual Report 2020) and Appendix C contains the Directors' responsibility statement (page 140 of the Annual Report 2020). Together these constitute the material required by Rule 6.3.5 of the Disclosure Guidance and Transparency Rules to be communicated to the media in unedited full text through a Regulatory Information Service. This material is not a substitute for reading the full Annual Report 2020. Any page numbers and cross-references in the extracted information below refer to page numbers in the Annual Report 2020.

P McCrory

Company Secretary

9 March 2021

Enquiries:

Investor Relations

British American Tobacco Investor Relations

Mike Nightingale / Victoria Buxton / William Houston / John Harney

+44 (0) 20 7845 1180 / 2012 / 1138 / 1263

British American Tobacco Press Office

+44 (0) 20 7845 2888 (24 hours) | @BATplc

APPIX A

GROUP PRINCIPAL RISKS

Overview

The principal risks that may affect the Group are set out on the following pages.

Each risk is considered in the context of the Group's strategy, as set out in this Strategic Report on pages 18 and 19. Following a description of each risk, its potential impact and management by the Group is summarised. Clear accountability is attached to each risk through the risk owner.

The Group has identified risks and is actively monitoring and taking action to manage the risks. This section focuses on those risks that the Directors believe to be the most important after assessment of the likelihood and potential impact on the business. Not all of these risks are within the control of the Group and other risks besides those listed may affect the Group's performance. Some risks may be unknown at present. Other risks, currently regarded as less material, could become material in the future.

The risks listed in this section and the activities being undertaken to manage them should

be considered in the context of the Group's internal control framework. This is described in the section on risk management and internal control in the corporate governance statement on pages 114 to 115. This section should also be read in the context of the cautionary statement on page 318.

A summary of all the risk factors (including the principal risks) which are monitored by the Board through the Group's risk register is set out in the Additional disclosures section on pages 288 to 306.

Assessment of Group Risk

During the year, the Directors have carried out a robust assessment of the principal risks and uncertainties facing the Group, including those that could impact delivery of its strategic objectives, business model, future performance, solvency or liquidity.

During the first half of 2020, the Board assessed that it was appropriate to include COVID-19 as a Group principal risk as reported in the Half-year Report, however as new working practices are implemented to reflect the current operating environment and associated risks are incorporated into existing Group risks, the Group no longer maintains COVID-19 as a principal risk (please see Group risk factors, page 294 for further information). The Group's current principal risks remain broadly unchanged compared to 2019 with regards to marketplace, excise and tax, operations, regulation and litigation risks, and continue to reflect the challenging external environment.

The viability statement below provides a broader assessment of long-term solvency and liquidity. The Directors considered a number of factors that may affect the resilience of the Group. Except for the risk 'injury, illness or death in the work place' the Directors have also assessed the potential impact of the principal risks that may impact the Group's viability.

Viability Statement

The Board has assessed the viability of the Group taking into account the current position and principal risks, in accordance with provision 31 of the 2018 UK Corporate Governance Code. Whilst the Directors have no reason to believe the Group will not be viable over a longer period, owing to the inherent uncertainty arising due to ongoing litigation and regulation, the period over which the Board considers it possible to form a reasonable expectation as to the Group's longer-term viability (that it will be able to continue in operation and meet its liabilities as they fall due) is three years.

In making this assessment of the Group's prospects, the Board considered the Group's strong cash generation from operating activities, access to external sources of financing (and ability to manage the impact of COVID-19). In doing so, the Directors recognised the Group's ability to utilise is geographic footprint and integrated operating model to minimise the impact of the pandemic on the Group's performance.

This assessment included a robust review of the Group's operational and financial processes and the principal risks (as indicated on pages 85 to 88) that may impact the Group's viability. These are considered, with the mitigating actions, at least once a year. The assessment included reverse stress test of the core drivers of the Group's performance to determine the impact of the risks (individually and in aggregate) whilst recognising that, from 2020, no external financial covenant exists with regards to the Group's financing facilities. The reverse stress testing did not identify any individual risk, based upon a prudent annual forecast, that would, if arising in isolation and without mitigation, impact the Group's viability within the 3 year confirmation period. Furthermore, the Board recognised that even if all the principal risks arose simultaneously, given the underlying strong free cash flow generation before the payment of dividends (2020: GBP7.3 billion), the Group would be able to undertake mitigating actions to meet the liabilities as they fall due.

The Board noted that the Group has access to a GBP6 billion credit facility (2020 undrawn), US (US$4 billion) and Euro (GBP3 billion) commercial paper programmes (2020: GBPnil outstanding) and GBP3.4 billion of bilateral agreements (2020: undrawn) which may be utilised to support the Group's ability to operate.

However, the Group is subject to uncertainties with regards to regulatory change and litigation, which may have a bearing on the Group's viability. The Group maintains, as referred to in note 27 in the Notes on the Accounts 'Contingent Liabilities and Financial Commitments,' that the defences of the Group's companies to all the various claims are meritorious on both law and the facts. If an adverse judgment is entered against any of the Group's companies in any case, an appeal may be made, the duration of which can be reasonably expected to last for a number of years.

Risks

Competition from illicit trade

Increased competition from illicit trade and illegal products - either local duty evaded, smuggled, counterfeits or non-regulatory compliant.

Time frame

Short/Long term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Society

Considered in viability statement

Yes

Impact

Erosion of goodwill, with lower volumes and reduced profits.

Reduced ability to take price increases.

Investment in trade marketing and distribution is undermined.

Counterfeit New Categories products and other illicit products could harm consumers, damaging goodwill, and/or the category (with lower volumes and reduced profits), potentially leading to misplaced claims against BAT and further regulation.

Mitigation activities across all categories

Dedicated Anti-Illicit Trade (AIT) teams operating at global and country levels; internal cross-functional levels; compliance procedures, toolkit and best practice shared.

Active engagement with key external stakeholders.

Cross-industry and multi-sector cooperation on a range of AIT issues.

Global AIT strategy supported by a research programme to further the understanding of the size and scope of the problem.

AIT Engagement Team (including a dedicated analytical laboratory and a forensic compliance team) work with enforcement agencies in pursuit of priority targets.

Tobacco, New Categories and other regulation interrupts growth strategy

The enactment of regulation that significantly impairs the Group's ability to communicate, differentiate, market or launch its products.

Time frame

Medium term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Society

Considered in viability statement

Yes

Impact

Erosion of brand value through commoditisation, the inability to launch innovations, differentiate products, maintain or build brand equity and leverage price.

Regulation in respect of menthol, Nicotine levels and New Categories may adversely impact individual brand portfolios.

Adverse impact on ability to compete within the legitimate tobacco, nicotine or New Categories industry and with illicit traders.

Reduced consumer acceptability of new product specifications, leading to consumers seeking alternatives in illicit markets.

Shocks to share price on the announcement or enactment of restrictive regulation.

Reduced ability to compete in future product categories and make new market entries.

Increased scope and severity of compliance regimes in new regulation leading to higher costs, greater complexity and potential reputational damage or fines for inadvertent breach.

EU Directive on single-use plastics could result in increased operational costs and/or adverse impact on sales volume and profit.

Please refer to pages 307 to 310 for details of tobacco and nicotine regulatory regimes under which the Group's businesses operate.

Mitigation activities

Engagement and litigation strategy coordinated and aligned across the Group to drive a balanced global policy framework for combustibles and New Categories.

Stakeholder mapping and prioritisation, developing robust compelling advocacy materials (with supporting evidence and data) and regulatory engagement programmes.

Regulatory risk assessment of marketing plans to ensure decisions are informed by an understanding of the potential regulatory environments.

Advocating the application of integrated regulatory proposals to governments and public health practitioners based on the harm reduction principles of New Categories.

Development of an integrated regulatory strategy that spans conventional combustibles and New Categories.

Training and capability programmes for End Markets to upskill Legal and External Affairs managers on combustible and New Categories product knowledge.

Direct access to online portal providing latest position and advocacy material for End Market engagement on combustibles and New Categories.

Inability to develop, commercialise and deliver the New Categories strategy

Risk of not capitalising on the opportunities in developing and commercialising successful, safe and consumer-appealing innovations.

Time frame

Long term

Strategic impact

New Categories

Combustibles

Simplification

Key Stakeholders

Consumers

Considered in viability statement

Yes

Impact

Failure to deliver Group strategic imperative, 2025 growth ambition (previously 2024) and 2030 consumer targets.

Potentially missed opportunities, unrecoverable costs and/or erosion of brand, with lower volumes and reduced profits.

Reputational damage and recall costs may arise in the event of defective product design or manufacture.

Loss of market share due to non-compliance of product portfolio with regulatory requirements.

Mitigation activities

Focus on product stewardship to ensure high-quality standards across portfolio.

Brand Expression, which sets out how our brand expresses itself (including through its logo, name, product, packaging etc.) deployed to lead End Markets via activation workshops and best practices shared.

Generating sufficient IP to develop competitive and sustainable products.

Accelerating digital and consumer analytics along with data management platforms for enhanced methodologies, insight generation and line of sight across the Group.

R&D is accredited to ISO9001 standard and laboratories are accredited to ISO17025 for key methods.

Market size reduction and consumer down-trading

The Group is faced with steep excise-led price increases and, due in part to the continuing difficult economic and regulatory environment in many countries, market contraction and consumer down-trading is a risk.

Time frame

Short/Medium term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Consumers

Shareholders

Considered in viability statement

Yes

Impact

Volume decline and portfolio mix erosion leading to lower profitability.

Funds to invest in growth opportunities are reduced.

Mitigation activities

Geographic spread mitigates impact at Group level.

Close monitoring of portfolio and pricing strategies across combustibles and New Categories, ensuring balanced portfolio of strong brands across key segments.

Overlap with many mitigation activities undertaken for other principal risks facing the Group, such as competition from illicit trade and significant excise increases or structure changes.

New Category growth and multi category approach.

Litigation

Product liability, regulatory or other significant cases (including investigations) may be lost or settled resulting in a material loss or other consequence.

Time frame

Long term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Shareholders

Considered in viability statement

Yes

Impact

Damages and fines, negative impact on reputation, disruption and loss of focus on the business.

Consolidated results of operations, cash flows and financial position could be materially affected, in a particular fiscal quarter or fiscal year, by region or country, by an unfavourable outcome or settlement of pending or future litigation, criminal prosecution or other contentious action.

Inability to sell products as a result of patent infringement action may restrict growth plans and competitiveness.

Mitigation activities

Consistent litigation and patent management strategy across the Group.

Expertise and legal talent maintained both within the Group and external partners.

Ongoing monitoring of key legislative and case law developments related to our business.

Delivery with Integrity compliance programme.

Please refer to note 27 in the Notes on the Accounts for details of contingent liabilities applicable to the Group.

Significant increases or structural changes in tobacco, nicotine and New Categories related taxes

The Group is exposed to unexpected and/or significant increases or structural changes in tobacco, nicotine and New Categories related taxes in key markets.

Time frame

Long term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Consumers

Society

Considered in viability statement

Yes

Impact

Consumers reject the Group's legitimate tax-paid products for products from illicit sources or cheaper alternatives.

Reduced legal industry volumes.

Reduced sales volume and/or portfolio erosion.

Partial absorption of excise increases leading to lower profitability.

Mitigation activities

Formal pricing and excise strategies, including Revenue Growth Management using a data science-led approach, with annual risk assessments and contingency plans across all products.

Pricing, excise and trade margin committees in markets, with global support.

Engagement with relevant local and international authorities where appropriate, in particular in relation to the increased risk to excise revenues from higher illicit trade.

Portfolio reviews to ensure appropriate balance and coverage across price segments.

Monitoring of economic indicators, government revenues and the political situation.

Foreign exchange rate exposures

The Group faces translational and transactional foreign exchange (FX) rate exposure for earnings/cash flows from its global business.

Time frame

Short/Medium term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Shareholders

Considered in viability statement

Yes

Impact

Fluctuations in FX rates of key currencies against sterling introduce volatility in reported earnings per share (EPS), cash flow and the balance sheet driven by translation into sterling of our financial results and these exposures are not normally hedged.

The dividend may be impacted if the payout ratio is not adjusted.

Differences in translation between earnings and net debt may affect key ratios used by credit rating agencies.

Volatility and/or increased costs in our business, due to transactional FX, may adversely impact financial performance.

Mitigation activities

While translational FX exposure is not hedged, its impact is identified in results presentations and financial disclosures; earnings are restated at constant rates for comparability.

Debt and interest are matched to assets and cash flows to mitigate volatility where possible and economic to do so.

Hedging strategy for transactional FX and framework is defined in the treasury policy, a global policy approved by the Board.

Illiquid currencies of many markets where hedging is either not possible or uneconomic are reviewed on a regular basis.

Geopolitical tensions

Geopolitical tensions, civil unrest, economic policy changes, global health crises, terrorism and organised crime have the potential to disrupt the Group's business in multiple markets.

Time frame

Medium term

Strategic impact

New Categories

Combustibles

Simplification

Considered in viability statement

Yes

Impact

Potential loss of life, loss of assets and disruption to supply chains and normal business processes.

Increased costs due to more complex supply chain arrangements and/or the cost of building new facilities or maintaining inefficient facilities.

Lower volumes as a result of not being able to trade in a country.

Higher taxes or other costs of doing business as a foreign company or the loss of assets as a result of nationalisation.

Mitigation activities

Physical and procedural security controls are in place, and constantly reviewed in accordance with our Security Risk Management process, for all field force and supply chain operations, with an emphasis on the protection of Group employees.

Globally integrated sourcing strategy and contingency sourcing arrangements.

Security risk modelling, including external risk assessments and the monitoring of geopolitical and economic policy developments worldwide.

Insurance cover and business continuity planning, including scenario planning and testing, and risk awareness training.

Solvency and liquidity

Liquidity (access to cash and sources of finance) is essential to maintaining the Group as a going concern in the short term (liquidity) and medium term (solvency).

Time frame

Short/Medium term

Strategic impact

New Categories

Combustibles

Key Stakeholders

Shareholders

Considered in viability statement

Yes

Impact

Inability to fund the business under the current capital structure resulting in missed strategic opportunities or inability to respond to threats.

Decline in our creditworthiness and increased funding costs for the Group.

Requirement to issue equity or seek new sources of capital.

Reputational risk of failure to manage the financial risk profile of the business, resulting in an erosion of shareholder value reflected in an underperforming share price.

Mitigation activities

Group policies include a set of financing principles and key performance indicators including the monitoring of credit ratings, interest cover, solvency and liquidity with regular reporting to

Corporate Finance Committee and the Board.

The Group targets an average centrally managed debt maturity of at least five years with no more than 20% of centrally managed debt maturing in a single rolling year.

The Group holds a two-tranche revolving credit facility of GBP6 bn syndicated across a wide banking group, consisting of a 364-day tranche (with two one-year extension options and a one-year term-out option) and a GBP3 bn five-year tranche (with two one-year extension options).

Liquidity pooling structures are in place to ensure that there is maximum mobilisation of cash liquidity within the Group.

Going concern and viability support papers are presented to the Board on a regular basis.

Injury, illness or death in the workplace

The risk of injury, death or ill health to employees and those who work with the business is a fundamental concern of the Group and can have a significant effect on its operations.

Time frame

Short term

Strategic impact

New Categories

Combustibles

Simplification

Key Stakeholders

Employees

Considered in viability statement

No

Impact

Serious injuries, ill health, disability or loss of life suffered by employees and the people who work with the Group.

Exposure to civil and criminal liability and the risk of prosecution from enforcement bodies and the cost of associated legal costs, fines and/or penalties.

Interruption of Group operations if issues are not addressed immediately.

High staff turnover or difficulty recruiting employees if perceived to have a poor Environment, Health and Safety (EHS) record.

Reputational damage to the Group.

Mitigation activities

Risk control systems in place to ensure equipment and infrastructure are provided and maintained.

EHS strategy aims to ensure that employees at all levels receive appropriate EHS training and information.

Behavioural-based safety programme to drive operations' safety performance, culture and closer to zero accidents.

Analysis of incidents undertaken regionally and globally by a dedicated team to identify increasing incident trends or high potential risks that require coordinated action.

Disputed taxes, interest and penalties

The Group may face significant financial penalties, including the payment of interest, in the event of an unfavourable ruling by a tax authority in a disputed area.

Time frame

Short/Medium term

Strategic impact

New Categories

Combustibles

Simplification

Key Stakeholders

Shareholders

Considered in viability statement

Yes

Impact

Significant fines and potential legal penalties.

Disruption and loss of focus on the business due to diversion of management time.

Impact on profit and dividend.

Mitigation activities

End market tax committees.

Internal tax function provides dedicated advice and guidance, and external advice sought where needed.

Engagement with tax authorities at Group, regional and individual market level.

Please refer to note 27 in the Notes on the Accounts for details of contingent liabilities applicable to the Group.

APPIX B

RELATED PARTY DISCLOSURES

The Group has a number of transactions and relationships with related parties, as defined in IAS 24 Related Party Disclosures, all of which are undertaken in the normal course of business. Transactions with CTBAT International Limited (a joint operation) are not included in these disclosures as the results are immaterial to the Group.

Transactions and balances with associates relate mainly to the sale and purchase of cigarettes and tobacco leaf. The Group's share of dividends from associates, included in other net income in the table below, was GBP394 million (2019: GBP239 million; 2018: GBP211 million).

 
                                                  2020               2019 2018 
                                                  GBPm               GBP m GBPm 
====================================  ================  ========================= 
T ransactions 
                                                                    511 473 (79) 
 - revenue                                        495                   (101) 
 - pu r chases                                    (80)                 248 216 
 - other net income                               388               42 26 (2) (1) 
 Amount s receivable at 31 December                33 
 Amount s payable at 31 December                  (5) 
====================================  ================  ========================= 
 

During 2020, the Group made a capital contribution in Brascuba Cigarrillos S.A. at a cost of GBP17 million (2019: GBP20 million) and increased its ownership of FE "Samfruit" JSC to 38.63% for GBP5 million.

During 2020, there was a capital reduction in CTBAT International Limited of approximately US$171 million with funds due to be remitted prorate to investors in 2021.

During 2019, the Group acquired 60% of VapeWild Holdings LLC and a minority stake in AYR Limited.

During 2018, the Group acquired a further 44% interest in British American Tobacco Myanmar Limited and a further 11% interest in British American Tobacco Vranje.

The key management personnel of British American Tobacco consist of the members of the Board of Directors of British American Tobacco p.l.c. and the members of the Management Board. No such person had any material interest during the year in a contract of significance (other than a service contract) with the Company or any subsidiary company. The term key management personnel in this context includes their close family members.

 
                                                      2020            201 9 2018 
                                                      GBPm             GBP m GBPm 
===================================================  =====  ===================== 
Th e total compensation for key management 
 personnel, including Directors, was: 
 - salaries and other short-term employee benefits      17             2 6 21 
 - post-employment benefits                              2              4 4 
 - share-based payments                                 13              23 18 
===================================================  =====  ===================== 
                                                        32            53 43 
===================================================  =====  ===================== 
 

The following table, which is not part of IAS24 disclosures, shows the aggregate emoluments of the Directors of the Company.

Executive Directors Chairman Non-Executive Directors Total

 
                           2020          201 9 2018        2020        201 9 2018           2020          201 9 2018             2020          201 9 2018 
                           GBP'000       GBP'00 0          GBP'000      GBP'00 0            GBP'000       GBP'00 0 GBP'000       GBP'000        GBP'00 0 
                                         GBP'000                        GBP'000                                                                 GBP'000 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
Sala r y ; 
 fees; benefits; 
 incentives 
 - sala ry                 2,026        2,356 2,211              -          -                     -                - -           2,026        2,356 2,211 
 - fees                       -               -                714           6 95 680         1,028              969 1,092        1,742       1, 664 1,772 
 - taxable benefits          744           608 427              77           1 37 116            72              310 303           893          1,055 846 
 - short-term 
  incentives                3,274        4,791 5,031             -           - -                  -               - - -           3,274       4, 791 5,031 
 - long-term 
  incentives                1,294        4,4 20 5,300            -           - -                  -                               1,294        4,420 5,300 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
Sub-total                  7,338       12, 175 12,969       791         832 796            1,100         1,2 79 1,395            9,229       14,286 15,160 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
Pension ; other 
 emoluments 
 - pension 
 - other emoluments           304           6 86 921             -          - -                   -            - -                  304           6 86 921 
                               20            47 50               -           - -                  -             - -                  20            47 50 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
Sub-total                   324           733 971                -         - -                    -           - -                 324           733 971 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
T ota l emoluments        7,662        1 2,908 13,940       791         832 796            1,100         1,2 79 1,395           9,553        15,019 16,131 
====================  ============  =================  ===========  =================  ============  =====================  ============  ================ 
 
 
Aggregat e gains on L TIP shares 
 exe r cised in the year 
=================================  ============================================================================ 
                                                                                           Pric       Aggregate 
                                                                  Exe r                     e per      gain 
                                                                  cised                     share 
                                             A war d date     L TI P       Exe r cis        (GBP)     (GBP) 
                                                               shares       e date 
=================================  =======================  ===========  ============  ==========  ============ 
Jack Bowles                                 2 7 Mar 2017         18,497   06 Apr 2020       29.62      547,881 
                                                                          08 June 
Tadeu Marroco                               2 7 Mar 2017        14,755     2020             31.23     460,799 
=================================  =======================  ===========  ============  ==========  ============ 
 
 
LTIP - Value of awards 2017 
============================  ===================================== 
                                                 Pric          Face 
                                                  e per       Value 
                                                  share 
                                     Shares    (GBP)(1)       (GBP) 
============================    ===========  ==========  ========== 
Jack Bowles                          26,463       52.11   1,378,987 
Tadeu Marroco                        21,109       52.11   1,099,990 
==============================  ===========  ==========  ========== 
 
   1.       For  information  only  as  awards  are  made  as  nil  cost  options. 
 
Sharesave- Aggregate Gains 
2020 
==============================  ====================================================================================== 
                                                                                              Price          Aggregate 
                                                                                          per share               gain 
                                          A war d date    Shares               Exercise       (GBP)              (GBP) 
                                                                                date 
==============================  ========================  ======  =====================  ==========  ================= 
Tadeu Marroco                            2 3 March 2015    495             09 June 2020       30.26                  0 
Sharesave- Value of award 2015 
==============================  ====================================================================================== 
                                                                                              Price               Face 
                                                                                          per share              Value 
                                                                   Shares                     (GBP)              (GBP) 
==============================  ========================  ======  =====================  ==========  ================= 
Tadeu Marroco                                                          495                    30.26             14.979 
 

APPIX C

DIRECTORS' RESPONSIBILITY STATEMENT

The responsibility statement set out below is solely for the purpose of complying with Disclosure Guidance and Transparency Rule 6.3.5R. This statement relates to and is extracted from the 2020 Annual Report. Responsibility is for the full 2020 Annual Report and not the extracted information presented in this announcement and the Preliminary Announcement. We confirm that to the best of our knowledge:

-- the financial statements, prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and

-- the Strategic Report and the Directors' Report include a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.

Forward looking statements

This announcement contains certain forward-looking statements, including "forward-looking" statements made within the meaning of U.S. Private Securities Litigation Reform Act 1995. These statements are often, but not always, made through the use of words or phrases such as "believe," "anticipate," "could," "may," "would," "should," "intend," "plan," "potential," "predict," "will," "expect," "estimate," "project," "positioned," "strategy," "outlook", "target" and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Group operates, including the projected future financial and operating impacts of the COVID-19 pandemic.

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results to differ materially from those currently anticipated. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; the inability to develop, commercialise and deliver the Group's New Categories strategy; the impact of market size reduction and consumer down-trading; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; the impact of significant increases or structural changes in tobacco, nicotine and New Categories related taxes; translational and transactional foreign exchange rate exposure; changes or differences in domestic or international economic or political conditions; the ability to maintain credit ratings and to fund the business under the current capital structure; the impact of serious injury, illness or death in the

workplace; adverse decisions by domestic or international regulatory bodies; and changes in the market position, businesses, financial condition, results of operations or prospects of the Group.

It is believed that the expectations reflected in this announcement are reasonable but they may be

affected by a wide range of variables that could cause actual results to differ materially from those

currently anticipated. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

No statement in this communication is intended to be a profit forecast and no statement in this communication should be interpreted to mean that earnings per share of BAT for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT.

Additional information concerning these and other factors can be found in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), including the Annual Report on Form 20-F filed on 9 March 2021 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC's website, http://www.sec.gov, and the Company's Annual Reports, which may be obtained free of charge from the British American Tobacco website www.bat.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSDKCBBNBKDDNK

(END) Dow Jones Newswires

March 09, 2021 09:00 ET (14:00 GMT)

British American Tobacco (LSE:BATS)
Historical Stock Chart
From Mar 2024 to May 2024 Click Here for more British American Tobacco Charts.
British American Tobacco (LSE:BATS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more British American Tobacco Charts.